Han C - Search Results

1

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1⁺ CD8 T cells.

Li H, Liu Z, Liu L, Zhang H, Han C, Girard L, Park H, Zhang A, Dong C, Ye J, Rayford A, Peyton M, Li X, Avila K, Cao X, Hu S, Alam MM, Akbay EA, Solis LM, Behrens C, Hernandez-Ruiz S, Lu W, Wistuba I, Heymach JV, Chisamore M, Micklem D, Gabra H, Gausdal G, Lorens JB, Li B, Fu YX, Minna JD, Brekken RA. Li H, et al. Among authors: han c. Cell Rep Med. 2022 Mar 15;3(3):100554. doi: 10.1016/j.xcrm.2022.100554. eCollection 2022 Mar 15. Cell Rep Med. 2022. PMID: 35492873 Free PMC article.

2

Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.

Luo M, Liu Z, Zhang X, Han C, Samandi LZ, Dong C, Sumer BD, Lea J, Fu YX, Gao J. Luo M, et al. Among authors: han c. J Control Release. 2019 Apr 28;300:154-160. doi: 10.1016/j.jconrel.2019.02.036. Epub 2019 Mar 4. J Control Release. 2019. PMID: 30844475

3

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8⁺ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX. Qiao J, et al. Among authors: han c. Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005. Cancer Cell. 2019. PMID: 31185213 Free article.

4

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX. Li X, et al. Among authors: han c. Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1. Nat Commun. 2019. PMID: 31324798 Free PMC article.

5

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.

Liu Z, Han C, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu YX. Liu Z, et al. Among authors: han c. Sci Immunol. 2019 Aug 9;4(38):eaav6473. doi: 10.1126/sciimmunol.aav6473. Sci Immunol. 2019. PMID: 31399492

6

Targeting innate sensing in the tumor microenvironment to improve immunotherapy.

Liu Z, Han C, Fu YX. Liu Z, et al. Among authors: han c. Cell Mol Immunol. 2020 Jan;17(1):13-26. doi: 10.1038/s41423-019-0341-y. Epub 2019 Dec 16. Cell Mol Immunol. 2020. PMID: 31844141 Free PMC article. Review.

7

Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling.

Han C, Liu Z, Zhang Y, Shen A, Dong C, Zhang A, Moore C, Ren Z, Lu C, Cao X, Zhang CL, Qiao J, Fu YX. Han C, et al. Nat Immunol. 2020 May;21(5):546-554. doi: 10.1038/s41590-020-0641-5. Epub 2020 Mar 30. Nat Immunol. 2020. PMID: 32231300

8

Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.

Mender I, Zhang A, Ren Z, Han C, Deng Y, Siteni S, Li H, Zhu J, Vemula A, Shay JW, Fu YX. Mender I, et al. Among authors: han c. Cancer Cell. 2020 Sep 14;38(3):400-411.e6. doi: 10.1016/j.ccell.2020.05.020. Epub 2020 Jul 2. Cancer Cell. 2020. PMID: 32619407 Free PMC article.

9

β-Catenin regulates tumor-derived PD-L1.

Han C, Fu YX. Han C, et al. J Exp Med. 2020 Nov 2;217(11):e20200684. doi: 10.1084/jem.20200684. J Exp Med. 2020. PMID: 32860048 Free PMC article.

10

Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling.

Han C, Liu Z, Zhang Y, Shen A, Dong C, Zhang A, Moore C, Ren Z, Lu C, Cao X, Zhang CL, Qiao J, Fu YX. Han C, et al. Nat Immunol. 2020 Nov;21(11):1470. doi: 10.1038/s41590-020-00805-0. Nat Immunol. 2020. PMID: 32939095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,345 results

Search Page